Prenatal morphine exposure decreases analgesia but not K+ channel activation

Lih Chu Chiou, Geng Chang Yeh, Shu Huai Fan, Cheng Hung How, Kuang Chieh Chuang, Pao Luh Tao

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The present study has investigated the possible supraspinal adaptive changes induced by prenatal administration of morphine, including morphine-induced supraspinal antinociception in vivo, the density and binding affinity of μ-opioid receptors in the brain and the cellular action of morphine in brain slices in vitro. The cellular action of morphine was assessed by its activation of K+ channels in the ventrolateral periaqueductal gray (PAG), a crucial area for the supraspinal analgesic effect of morphine. Female rats were treated with morphine 7 days before mating at 2 mg/kg. The treatment was continued during pregnancy and after delivery at doses which increased by 1 mg/kg every 2 weeks. Experiments were conducted in the offspring at p14 days. Prenatal morphine exposure induced tolerance to supraspinal morphine-induced tail-flick response. The binding affinity and maximal binding of [3H]DAMGO in whole brain were not significant different between the morphine- or saline-treated dams. Autoradiographic analysis shows that the μ-opioid receptor density was decreased in the striatum, thalamus and amygdala but not in the midbrain, nucleus accumbens, hippocampus or cortex in morphine offspring. In ventrolateral PAG neurons, morphine activated inwardly rectifying K+ channels in 59% of recorded neurons of morphine offspring. Neither the magnitude of K+ channel activation nor the percentage of sensitive neurons was different between the saline- and morphine-treated offspring. It is concluded that prenatal morphine exposure induces tolerance to supraspinal analgesia and this tolerance is not attributed to a change in the μ-opioid receptor density or the receptor-function coupling efficiency in the midbrain periaqueductal gray.

Original languageEnglish
Pages (from-to)239-242
Number of pages4
JournalNeuroReport
Volume14
Issue number2
DOIs
Publication statusPublished - Feb 10 2003
Externally publishedYes

Fingerprint

Analgesia
Morphine
Periaqueductal Gray
Opioid Receptors
Mesencephalon
Neurons
Brain
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Inwardly Rectifying Potassium Channel
Nucleus Accumbens
Amygdala
Thalamus
Analgesics
Tail
Hippocampus

Keywords

  • μ-Opioid receptors
  • Analgesia
  • Antinociception
  • Inwardly rectifying K channels
  • Morphine tolerance
  • Offspring toxicity
  • Periaqueductal gray

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chiou, L. C., Yeh, G. C., Fan, S. H., How, C. H., Chuang, K. C., & Tao, P. L. (2003). Prenatal morphine exposure decreases analgesia but not K+ channel activation. NeuroReport, 14(2), 239-242. https://doi.org/10.1097/00001756-200302100-00016

Prenatal morphine exposure decreases analgesia but not K+ channel activation. / Chiou, Lih Chu; Yeh, Geng Chang; Fan, Shu Huai; How, Cheng Hung; Chuang, Kuang Chieh; Tao, Pao Luh.

In: NeuroReport, Vol. 14, No. 2, 10.02.2003, p. 239-242.

Research output: Contribution to journalArticle

Chiou, LC, Yeh, GC, Fan, SH, How, CH, Chuang, KC & Tao, PL 2003, 'Prenatal morphine exposure decreases analgesia but not K+ channel activation', NeuroReport, vol. 14, no. 2, pp. 239-242. https://doi.org/10.1097/00001756-200302100-00016
Chiou, Lih Chu ; Yeh, Geng Chang ; Fan, Shu Huai ; How, Cheng Hung ; Chuang, Kuang Chieh ; Tao, Pao Luh. / Prenatal morphine exposure decreases analgesia but not K+ channel activation. In: NeuroReport. 2003 ; Vol. 14, No. 2. pp. 239-242.
@article{0478b04df72c410db93388e0a207c667,
title = "Prenatal morphine exposure decreases analgesia but not K+ channel activation",
abstract = "The present study has investigated the possible supraspinal adaptive changes induced by prenatal administration of morphine, including morphine-induced supraspinal antinociception in vivo, the density and binding affinity of μ-opioid receptors in the brain and the cellular action of morphine in brain slices in vitro. The cellular action of morphine was assessed by its activation of K+ channels in the ventrolateral periaqueductal gray (PAG), a crucial area for the supraspinal analgesic effect of morphine. Female rats were treated with morphine 7 days before mating at 2 mg/kg. The treatment was continued during pregnancy and after delivery at doses which increased by 1 mg/kg every 2 weeks. Experiments were conducted in the offspring at p14 days. Prenatal morphine exposure induced tolerance to supraspinal morphine-induced tail-flick response. The binding affinity and maximal binding of [3H]DAMGO in whole brain were not significant different between the morphine- or saline-treated dams. Autoradiographic analysis shows that the μ-opioid receptor density was decreased in the striatum, thalamus and amygdala but not in the midbrain, nucleus accumbens, hippocampus or cortex in morphine offspring. In ventrolateral PAG neurons, morphine activated inwardly rectifying K+ channels in 59{\%} of recorded neurons of morphine offspring. Neither the magnitude of K+ channel activation nor the percentage of sensitive neurons was different between the saline- and morphine-treated offspring. It is concluded that prenatal morphine exposure induces tolerance to supraspinal analgesia and this tolerance is not attributed to a change in the μ-opioid receptor density or the receptor-function coupling efficiency in the midbrain periaqueductal gray.",
keywords = "μ-Opioid receptors, Analgesia, Antinociception, Inwardly rectifying K channels, Morphine tolerance, Offspring toxicity, Periaqueductal gray",
author = "Chiou, {Lih Chu} and Yeh, {Geng Chang} and Fan, {Shu Huai} and How, {Cheng Hung} and Chuang, {Kuang Chieh} and Tao, {Pao Luh}",
year = "2003",
month = "2",
day = "10",
doi = "10.1097/00001756-200302100-00016",
language = "English",
volume = "14",
pages = "239--242",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Prenatal morphine exposure decreases analgesia but not K+ channel activation

AU - Chiou, Lih Chu

AU - Yeh, Geng Chang

AU - Fan, Shu Huai

AU - How, Cheng Hung

AU - Chuang, Kuang Chieh

AU - Tao, Pao Luh

PY - 2003/2/10

Y1 - 2003/2/10

N2 - The present study has investigated the possible supraspinal adaptive changes induced by prenatal administration of morphine, including morphine-induced supraspinal antinociception in vivo, the density and binding affinity of μ-opioid receptors in the brain and the cellular action of morphine in brain slices in vitro. The cellular action of morphine was assessed by its activation of K+ channels in the ventrolateral periaqueductal gray (PAG), a crucial area for the supraspinal analgesic effect of morphine. Female rats were treated with morphine 7 days before mating at 2 mg/kg. The treatment was continued during pregnancy and after delivery at doses which increased by 1 mg/kg every 2 weeks. Experiments were conducted in the offspring at p14 days. Prenatal morphine exposure induced tolerance to supraspinal morphine-induced tail-flick response. The binding affinity and maximal binding of [3H]DAMGO in whole brain were not significant different between the morphine- or saline-treated dams. Autoradiographic analysis shows that the μ-opioid receptor density was decreased in the striatum, thalamus and amygdala but not in the midbrain, nucleus accumbens, hippocampus or cortex in morphine offspring. In ventrolateral PAG neurons, morphine activated inwardly rectifying K+ channels in 59% of recorded neurons of morphine offspring. Neither the magnitude of K+ channel activation nor the percentage of sensitive neurons was different between the saline- and morphine-treated offspring. It is concluded that prenatal morphine exposure induces tolerance to supraspinal analgesia and this tolerance is not attributed to a change in the μ-opioid receptor density or the receptor-function coupling efficiency in the midbrain periaqueductal gray.

AB - The present study has investigated the possible supraspinal adaptive changes induced by prenatal administration of morphine, including morphine-induced supraspinal antinociception in vivo, the density and binding affinity of μ-opioid receptors in the brain and the cellular action of morphine in brain slices in vitro. The cellular action of morphine was assessed by its activation of K+ channels in the ventrolateral periaqueductal gray (PAG), a crucial area for the supraspinal analgesic effect of morphine. Female rats were treated with morphine 7 days before mating at 2 mg/kg. The treatment was continued during pregnancy and after delivery at doses which increased by 1 mg/kg every 2 weeks. Experiments were conducted in the offspring at p14 days. Prenatal morphine exposure induced tolerance to supraspinal morphine-induced tail-flick response. The binding affinity and maximal binding of [3H]DAMGO in whole brain were not significant different between the morphine- or saline-treated dams. Autoradiographic analysis shows that the μ-opioid receptor density was decreased in the striatum, thalamus and amygdala but not in the midbrain, nucleus accumbens, hippocampus or cortex in morphine offspring. In ventrolateral PAG neurons, morphine activated inwardly rectifying K+ channels in 59% of recorded neurons of morphine offspring. Neither the magnitude of K+ channel activation nor the percentage of sensitive neurons was different between the saline- and morphine-treated offspring. It is concluded that prenatal morphine exposure induces tolerance to supraspinal analgesia and this tolerance is not attributed to a change in the μ-opioid receptor density or the receptor-function coupling efficiency in the midbrain periaqueductal gray.

KW - μ-Opioid receptors

KW - Analgesia

KW - Antinociception

KW - Inwardly rectifying K channels

KW - Morphine tolerance

KW - Offspring toxicity

KW - Periaqueductal gray

UR - http://www.scopus.com/inward/record.url?scp=0345269235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345269235&partnerID=8YFLogxK

U2 - 10.1097/00001756-200302100-00016

DO - 10.1097/00001756-200302100-00016

M3 - Article

VL - 14

SP - 239

EP - 242

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 2

ER -